[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.206.194.83. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
April 1986

ELISA in the Diagnosis of Neurocysticercosis

Author Affiliations

From the Research Division, Neuroimmunology Department, Instituto Nacional de Neurologia y Neurocirugia, Mexico City.

Arch Neurol. 1986;43(4):353-356. doi:10.1001/archneur.1986.00520040039016
Abstract

• IgM antibodies against cysticercus antigens were measured by enzymelinked immunosorbent assay (ELISA) in 133 serum and 126 cerebrospinal fluid (CSF) samples from patients with active neurocysticercosis (NCC), in 61 serum and 32 CSF samples from patients with inactive NCC, and in 556 serum and 449 CSF samples from patients with other neurological disorders. For diagnosis of active NCC the test showed 50% sensitivity with 70% specificity in serum and 87% sensitivity with 95% specificity in CSF. We concluded that the use of the ELISA with serum is not reliable for diagnosis of NCC and therefore cannot be used routinely for the detection of cases or epidemiological studies. Conversely, ELISA used with CSF is highly dependable for detecting all forms of active NCC. The possible explanations for the discrepancy between serum and CSF results are discussed.

×